The use of the VerifyNow system to monitor antiplatelet therapy: a review of the current evidence (Q37315628)

19 August 2017

1 reference

title

The use of the VerifyNow system to monitor antiplatelet therapy: a review of the current evidence (English)

1 reference

19 August 2017

J W van Werkum

1

1 reference

19 August 2017

A M Harmsze

2

1 reference

19 August 2017

E H A M Elsenberg

3

1 reference

19 August 2017

H J Bouman

4

1 reference

19 August 2017

J M ten Berg

5

1 reference

19 August 2017

C M Hackeng

6

1 reference

19 August 2017

1 November 2008

1 reference

19 August 2017

1 reference

19 August 2017

19

1 reference

19 August 2017

7

1 reference

19 August 2017

479-488

1 reference

Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial

19 August 2017

1 reference

https://api.crossref.org/works/10.1080%2F09537100802317918

Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09537100802317918

Low-dose aspirin for the prevention of atherothrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09537100802317918

Regulation of platelet functions by P2 receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09537100802317918

Variability in platelet responsiveness to clopidogrel among 544 individuals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09537100802317918

Platelet reactivity in patients and recurrent events post-stenting: results of the PREPARE POST-STENTING Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09537100802317918

Benefit of a 600-mg loading dose of clopidogrel on platelet reactivity and clinical outcomes in patients with non-ST-segment elevation acute coronary syndrome undergoing coronary stenting.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09537100802317918

Impact of platelet reactivity after clopidogrel administration on drug-eluting stent thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09537100802317918

Clopidogrel resistance is associated with increased risk of recurrent atherothrombotic events in patients with acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09537100802317918

Monitoring antiplatelet therapy with point-of-care platelet function assays: a review of the evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09537100802317918

The platelet function dose-response to abciximab during percutaneous coronary revascularization is variable

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09537100802317918

Variability in extent of platelet function inhibition after administration of optimal dose of glycoprotein IIb/IIIa receptor blockers in patients undergoing a high-risk percutaneous coronary intervention.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09537100802317918

Effectiveness of tirofiban, eptifibatide, and abciximab in minimizing myocardial necrosis during percutaneous coronary intervention (TEAM pilot study).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09537100802317918

Impact--the cone and plate(let) analyzer: testing platelet function and anti-platelet drug response

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09537100802317918

Overestimation of platelet aspirin resistance detection by thrombelastograph platelet mapping and validation by conventional aggregometry using arachidonic acid stimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09537100802317918

Rapid platelet-function assay: an automated and quantitative cartridge-based method

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09537100802317918

Antiplatelet effects of abciximab, tirofiban and eptifibatide in patients undergoing coronary stenting

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09537100802317918

The Ultegra rapid platelet-function assay: comparison to standard platelet function assays in patients undergoing percutaneous coronary intervention with abciximab therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09537100802317918

Comparison of GP IIB/IIIA inhibitors and their activity as measured by aggregometry, flow cytometry, single platelet counting, and the rapid platelet function analyzer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09537100802317918

Point-of-care measured platelet inhibition correlates with a reduced risk of an adverse cardiac event after percutaneous coronary intervention: results of the GOLD (AU-Assessing Ultegra) multicenter study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09537100802317918

Assessing aspirin responsiveness in subjects with multiple risk factors for vascular disease with a rapid platelet function analyzer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09537100802317918

Platelet function measured by VerifyNow identifies generalized high platelet reactivity in aspirin treated patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09537100802317918

Screening for aspirin responsiveness after transient ischemic attack and stroke: comparison of 2 point-of-care platelet function tests with optical aggregometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09537100802317918

Comparison of different methods to evaluate the effect of aspirin on platelet function in high-risk patients with ischemic heart disease receiving dual antiplatelet treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09537100802317918

A comparison of six major platelet function tests to determine the prevalence of aspirin resistance in patients with stable coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09537100802317918

Low-dose aspirin increases aspirin resistance in patients with coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09537100802317918

Incidence of aspirin nonresponsiveness using the Ultegra Rapid Platelet Function Assay-ASA

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09537100802317918

Frequency of aspirin resistance in a community hospital

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09537100802317918

Monitoring platelet inhibition after clopidogrel with the VerifyNow-P2Y12(R) rapid analyzer: the VERIfy Thrombosis risk ASsessment (VERITAS) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09537100802317918

A head-to-head comparison between the VerifyNow P2Y12 assay and light transmittance aggregometry for monitoring the individual platelet response to clopidogrel in patients undergoing elective percutaneous coronary intervention.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09537100802317918

Validation of a VerifyNow-P2Y12 cartridge for monitoring platelet inhibition with clopidogrel.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09537100802317918

Platelet function monitoring in patients with coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09537100802317918

10.1080/09537100802317918

21 January 2018

Identifiers

DOI

1 reference

19 August 2017

1 reference